Skip to main content
. 2017 Sep 1;26(17):1236–1246. doi: 10.1089/scd.2017.0123

FIG. 6.

FIG. 6.

CSC-enriched SLC7A11-overexpressing U251 cells maintain higher viability under basal conditions and when treated with Temozolomide (TMZ) compared with control cells. Single cells were plated after 2-week enrichment for CSCs and then treated with or without 300 μM TMZ. Viability was measured after 72 h of treatment. Data shown are mean ± SD from a representative experiment. Data shown are mean ± SD from a representative experiment where *** indicates P < 0.001.